Quercetin reverses EGF-induced epithelial to mesenchymal transition and invasiveness in prostate cancer (PC-3) cell line via EGFR/PI3K/Akt pathway

Journal of Nutritional Biochemistry

Volumn 25, Issue 11, 2014, Pages 1132-1139

  Bhat, Firdous Ahmad ^a   Sharmila, G ^a   Balakrishnan, S ^a   Arunkumar, R ^a   Elumalai, P ^a   Suganya, S ^a   Raja Singh, P ^a   Srinivasan, N ^a   Arunakaran, J ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

E cadherin; Epidermal growth factor; Epithelial mesenchymal transition; N cadherin; Vimentin

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; QUERCETIN; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; UVOMORULIN; VASCULAR CELL ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; PRIMER DNA; PROTEIN KINASE C; PROTEIN KINASE D;

ARTICLE; CELL ADHESION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFECT; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; PROSTATE CANCER; PROSTATE CANCER CELL LINE; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE; TUMOR INVASION;

BASE SEQUENCE; CELL LINE, TUMOR; DNA PRIMERS; EPIDERMAL GROWTH FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; NEOPLASM INVASIVENESS; PHOSPHATIDYLINOSITOL 3-KINASES; PROSTATIC NEOPLASMS; PROTEIN KINASE C; QUERCETIN; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84908231754     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2014.06.008     Document Type: Article

References (40)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics. CA Cancer J Clin 2011, 60(5):277-300.
2. Bono J.S., Oudard S., Ozguroglu S., Hansen J.P., Machiels I., Kocak G., et al. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomized open-label trial. Lancet 2010, 76:1147-1154.
3. Huber M.A., Kraut N., Beug H. Molecular requirements for epithelial mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005, 17:548-558.
4. Thiery J.P., Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006, 7:131-142.
5. Hazan R.B., Qiao R., Keren R., Badano I., Suyama K. Cadherin switch in tumor progression. Ann N Y Acad Sci 2004, 1014:155-163.
6. Qiao M., Sheng S., Pardee A.B. Metastasis and AKT activation. Cell Cycle 2008, 7:2991-2996.
7. Yin Y., Wang C., Liu T., Zhao G., Zha Y., Yang M. Expression of snail in pancreatic cancer promotes metastasis and chemoresistance. J Surg Res 2007, 141(2):196-203.
8. Cho H.J., Baek K.E., Saika S., Jeong J.M., Yoo J. Snail is required for transforming growth factor-beta-induced epithelial-mesenchymal transition by activating PI3 kinase/Akt signal pathway. Biochem Biophys Res Commun 2007, 353(2):337-343.
9. Mariotti A., Perotti A., Sessa C., Ruegg C. N-cadherin as a therapeutic target in cancer. Expert Opin Investig Drugs 2007, 16:451-465.
10. Gan Y., Shi C., Inge L., Hibner M., Balducci J., Huang Y. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells. Oncogene 2010, 29:4947-4958.
11. Hynes N.E., Lane H.A. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 2005, 5:341-354.
12. Barr S., Thomson S., Buck E., Russo S., Petti F., Sujka-Kwok I., et al. Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions. Clin Exp Metastasis 2008, 25:685-693.
13. Nicolas C., Sebastien F., Maria C.M., Ramaroson A. Anticancer properties of flavonoids: roles in various stages of carcinogenesis. Cardiovasc Hematol Agents Med Chem 2011, 9:1-16.
14. Bischoff S.C. Quercetin: potentials in the prevention and therapy of disease. Curr Opin Clin Nutr Metab Care 2008, 11:733-740.
15. Murakami A., Ashida H., Terao J. Multitargeted cancer prevention by quercetin. Cancer Lett 2008, 269:315-325.
16. Senthilkumar K., Arunkumar R., Elumalai P., Sharmila G., Gunadharini D.N., Banudevi S., et al. Quercetin inhibits invasion, migration and signaling molecules involved in cell survival and proliferation of prostate cancer cell line (PC-3). Cell Biochem Funct 2011, 29(2):87-95.
17. Mossmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
18. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin-Phenol reagent. J Biol 1951, 193:265-274.
19. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
20. Thomas D.S., Kenneth J.L. Analyzing real-time PCR data by the comparative CT method. Nat Protoc 2008, 3:1101-1108.
21. Thiery J.P. Epithelial-mesenchymal transitions in tumor progression. Nat Rev Cancer 2002, 2:442-454.
22. Klymkowsky M.W., Savagner P. Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. Am J Pathol 2009, 174:1588-1593.
23. Umbas R., Isaacs W.B., Bringuier P.P., Schaafsma H., et al. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micro-metastatic and primary breast carcinoma cells. Clin Cancer Res 2005, 11(22):8006-8014.
24. Zimmerman T., Blanco F.J. Inhibitors targeting the LFA-1/ICAM-1 cell adhesion interaction: design and mechanism of action. Curr Pharm Des 2008, 14:2128-2139.
25. Duperray A., Languino L.R., Plescia J., McDowall A., Hogg N., Craig A.G., et al. Molecular identification of a novel fibrinogen binding site on the first domain of ICAM-1 regulating leukocyte-endothelium bridging. J Biol Chem 1997, 272:435-441.
26. Yang S.F., Chen M.K., Hsieh Y.S., Chung T.T., Hsieh Y.H., Lin C.W., et al. Prostaglandin E2/EP1 signaling pathway enhances intercellular adhesion molecule 1 (ICAM-1) expression and cell motility in oral cancer cells. J Biol Chem 2010, 285:29808-29816.
27. Roche Y., Pasquier D., Rambeaud J.J., Seigneurin D., Duperray A. Fibrinogen mediates bladder cancer cell migration in an ICAM-1-dependent pathway. Thromb Haemost 2003, 89:1089-1097.
28. Grothey A., Heistermann P., Philippou S., Voigtmann R. Serum levels of soluble intercellular adhesion molecule-1 (ICAM-1, CD54) in patients with non-small-cell lung cancer: correlation with histological expression of ICAM-1 and tumor stage. Br J Cancer 1998, 77:801-807.
29. Chen Q., Zhang X.H., Massague J. Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. Cancer Cell 2011, 20:538-549.
30. Lu X., Mu E., Wei Y., Riethdorf S., Yang Q., Yuan M., et al. VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging alpha4beta1-positive osteoclast progenitors. Cancer Cell 2011, 20:701-714.
31. Ruco L.P., de Laat P.A., Matteucci C., Bernasconi S., Sciacca F.M., van der Kwast T.H., et al. Expression of ICAM-1 and VCAM-1 in human malignant mesothelioma. J Pathol 1996, 179:266-271.
32. Shin J., Kim J., Ryu B., Chi S.G., Park H. Caveolin-1 is associated with VCAM-1 dependent adhesion of gastric cancer cells to endothelial cells. Cell Physiol Biochem 2006, 17:211-220.
33. Ivaska J. Vimentin: central hub in EMT induction?. Small GTPases 2011, 2(1):51-53.
34. Olmeda D., Jorda M., Peinado H., Fabra A., Cano A. Snail silencing effectively suppresses tumor growth and invasiveness. Oncogene 2006, 26:1862-1874.
35. Hemavathy K., Ashraf S.I. Snail/slug family of repressors: slowly going into the fast lane of development and cancer. Gene 2000, 257:1-2.
36. Alexander N.R., Tran N.L., Rekapally H., Summers C.E., Glackin C., Heimark R.L. N-cadherin gene expression in prostate carcinoma is modulated by integrin dependent nuclear translocation of Twist1. Cancer Res 2006, 66:3365-3369.
37. Hipp S., Walch A., Schuster T., Losko S., Laux H., Bolton T., et al. Activation of epidermal growth factor receptor results in Snail protein but not mRNA over-expression in endometrial cancer. J Cell Mol Med 2009, 13:3858-3867.
38. Ahmed N., Maines B.S., Quinn M.A., Unger W.G., Dedhar S., Auersperg N. Molecular pathways regulating EGF-induced epithelial-mesenchymal transition in human ovarian surface epithelium. Am J Physiol Cell Physiol 2006, 290:1532-1542.
39. Chen J.C., Klausen C., Leung P.C. Hydrogen peroxide mediates EGF induced down-regulation of E-cadherin expression via p38 MAPK and snail in human ovarian cancer cells. Mol Endocrinol 2010, 24:1569-1580.
40. Chin Y.R., Toker A. Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer. Cell Signal 2009, 21:470-476.